載入...
Development of tumor lysis syndrome (TLS): A potential risk factor in cancer patients receiving anticancer therapy
Tumor lysis syndrome (TLS) is characterized by hyperuricaemia, hyperphosphatemia, hyperkalaemia, as well as hypocalcaemia due to the breakdown of tumor cells undergoing cancer therapy (chemo/radio). Therefore it is of interest to evaluate oxidative stress using selective biological markers [Malondia...
Na minha lista:
| 發表在: | Bioinformation |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Biomedical Informatics
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4261116/ https://ncbi.nlm.nih.gov/pubmed/25512688 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630010703 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|